Global Recognition of Qualified Toxicologic Pathologists: Where We Are Now and Where We Need to Go (Reprinted from Toxicologic Pathology, vol 20, pg 267, 2007)

被引：12

作者：

Ettlin, Robert A. ^{[1
]}

Bolon, Brad ^{[2
]}

Pyrah, Ian ^{[3
]}

Konishi, Yoichi ^{[4
]}

Black, Hugh E. ^{[5
]}

机构：

[1] Novartis Pharma AG, CH-4056 Basel, Switzerland

[2] GEMpath Inc, Cedar City, UT USA

[3] Amgen Inc, Thousand Oaks, CA USA

[4] IFSTP Japan Off, Sakai, Osaka, Japan

[5] Hugh E Black & Associates, Sparta, NJ USA

来源：

TOXICOLOGIC PATHOLOGY | 2008年 / 36卷 / 05期

关键词：

International Academy of Toxicologic Pathologists (IATP); International Federation of Societies of Toxicologic Pathologists (IFSTP); proficiency; toxicologic pathology/pathologists;

D O I：

10.1177/0192623308320281

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Although there are a few national schemes for accreditation/certification of toxicologic pathologists (e.g., in Japan and the United Kingdom), a global recognition system for bench toxicologic pathologists is missing, as are universal standards defining their core competencies. This paper summarizes basic means regarding how proficiency in toxicologic pathology is acquired, provides an overview over examinations of interest to toxicologic pathologists, and emphasizes the value of practical experience in the field. The paper then discusses basic approaches to evaluate the proficiency of toxicologic pathologists and examines potential means to recognize qualified toxicologic pathologists. With progressive globalization, it is important that the toxicologic pathology community deepens the discussion regarding a global recognition mechanism for their discipline.

引用

页码：753 / 759

页数：7